271 related articles for article (PubMed ID: 25980001)
1. Study on the comparative activity of echinocandins on murine gut colonization by Candida albicans.
Maraki S; Hamilos G; Dimopoulou D; Andrianaki AM; Karageorgiadis AS; Kyvernitakis A; Lionakis S; Kofteridis DP; Samonis G
Med Mycol; 2015 Aug; 53(6):597-602. PubMed ID: 25980001
[TBL] [Abstract][Full Text] [Related]
2. Effects of levofloxacin, moxifloxacin and prulifloxacin on murine gut colonization by Candida albicans.
Maraki S; Lionakis S; Ntaoukakis M; Barbounakis E; Ntasis E; Kofteridis DP; Samonis G
Med Mycol; 2011 May; 49(4):419-23. PubMed ID: 21108571
[TBL] [Abstract][Full Text] [Related]
3. Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species.
Ou HT; Lee TY; Chen YC; Charbonneau C
BMC Infect Dis; 2017 Jul; 17(1):481. PubMed ID: 28693479
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species.
Cornely OA; Vazquez J; De Waele J; Betts R; Rotstein C; Nucci M; Pappas PG; Ullmann AJ
Mycoses; 2014 Feb; 57(2):79-89. PubMed ID: 23786573
[TBL] [Abstract][Full Text] [Related]
5. Saccharomyces boulardii and Candida albicans experimental colonization of the murine gut.
Samonis G; Falagas ME; Lionakis S; Ntaoukakis M; Kofteridis DP; Ntalas I; Maraki S
Med Mycol; 2011 May; 49(4):395-9. PubMed ID: 21077734
[TBL] [Abstract][Full Text] [Related]
6. Effects of tigecycline and daptomycin on murine gut colonization by Candida albicans.
Samonis G; Mantadakis E; Barbounakis E; Kofteridis D; Papadakis G; Sifaki L; Maraki S
Mycoses; 2008 Jul; 51(4):324-7. PubMed ID: 18855845
[TBL] [Abstract][Full Text] [Related]
7. Effects of cefepime, cefixime and ceftibuten on murine gut colonization by Candida albicans.
Maraki S; Barbounakis E; Chatzinikolaou I; Anatoliotakis N; Plataki M; Tselentis Y; Samonis G
Chemotherapy; 1998; 44(6):405-8. PubMed ID: 9755300
[TBL] [Abstract][Full Text] [Related]
8. Caspofungin dose escalation for invasive candidiasis due to resistant Candida albicans.
Wiederhold NP; Najvar LK; Bocanegra RA; Kirkpatrick WR; Patterson TF
Antimicrob Agents Chemother; 2011 Jul; 55(7):3254-60. PubMed ID: 21502632
[TBL] [Abstract][Full Text] [Related]
9. Candida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution.
Liew YX; Teo J; Too IA; Ngan CC; Tan AL; Chlebicki MP; Kwa AL; Lee W
BMC Infect Dis; 2015 Jul; 15():256. PubMed ID: 26137997
[TBL] [Abstract][Full Text] [Related]
10. Echinocandins: The Expanding Antifungal Armamentarium.
Aguilar-Zapata D; Petraitiene R; Petraitis V
Clin Infect Dis; 2015 Dec; 61 Suppl 6():S604-11. PubMed ID: 26567277
[TBL] [Abstract][Full Text] [Related]
11. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics of a Long-Acting Echinocandin, CD101, in a Neutropenic Invasive-Candidiasis Murine Model Using an Extended-Interval Dosing Design.
Lepak AJ; Zhao M; VanScoy B; Ambrose PG; Andes DR
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203480
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of ertapenem, imipenem, and meropenem on the colonization of the gastrointestinal tract of mice by Candida albicans.
Samonis G; Maraki S; Leventakos K; Spanaki AM; Kateifidis A; Galanakis E; Tselentis Y; Falagas ME; Mantadakis E
Med Mycol; 2006 May; 44(3):233-5. PubMed ID: 16702102
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of micafungin for the treatment of invasive candidiasis and candidaemia in patients with neutropenia.
Chandrasekar P; Sirohi B; Seibel NL; Hsu JW; Azie N; Wu C; Ruhnke M
Mycoses; 2018 May; 61(5):331-336. PubMed ID: 29364548
[TBL] [Abstract][Full Text] [Related]
15. Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome.
Reboli AC; Shorr AF; Rotstein C; Pappas PG; Kett DH; Schlamm HT; Reisman AL; Biswas P; Walsh TJ
BMC Infect Dis; 2011 Sep; 11():261. PubMed ID: 21961941
[TBL] [Abstract][Full Text] [Related]
16. Effects of carbapenems and their combination with amikacin on murine gut colonisation by Candida albicans.
Samonis G; Galanakis E; Ntaoukakis M; Sarchianaki E; Spathopoulou T; Dimopoulou D; Kofteridis DP; Maraki S
Mycoses; 2013 Mar; 56(2):105-9. PubMed ID: 22680984
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Sensititre Yeast One microdilution method for susceptibility testing of Candida species to anidulafungin, caspofungin, and micafungin.
García-Agudo L; García-Martos P; Martos-Cañadas J; Aznar-Marín P; Marín-Casanova P; Rodríguez-Iglesias M
Rev Esp Quimioter; 2012 Dec; 25(4):256-60. PubMed ID: 23303256
[TBL] [Abstract][Full Text] [Related]
18. The investigational agent E1210 is effective in treatment of experimental invasive candidiasis caused by resistant Candida albicans.
Wiederhold NP; Najvar LK; Fothergill AW; McCarthy DI; Bocanegra R; Olivo M; Kirkpatrick WR; Everson MP; Duncanson FP; Patterson TF
Antimicrob Agents Chemother; 2015 Jan; 59(1):690-2. PubMed ID: 25331706
[TBL] [Abstract][Full Text] [Related]
19. Risk factors of mortality and comparative in-vitro efficacy of anidulafungin, caspofungin, and micafungin for candidemia.
Lee SC; Lee CW; Shih HJ; Huang SH; Chiou MJ; See LC
J Microbiol Immunol Infect; 2014 Jun; 47(3):245-53. PubMed ID: 24246191
[TBL] [Abstract][Full Text] [Related]
20. Effect of ketoconazole, itraconazole and fluconazole on the gastrointestinal colonization of mice by Candida albicans.
Samonis G; Maraki S; Hajiioannou I; Chatzinikolaou I; Rolston KV; Bodey GP; Kontoyiannis DP
J Chemother; 2001 Feb; 13(1):66-9. PubMed ID: 11233803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
